Citations

Mayo Clinic

Showing 10 of 108585 citations.

Milestones in CT: Past, Present, and Future
McCollough, Cynthia H. , Rajiah, Prabhakar , McCollough, Cynthia H , Rajiah, Prabhakar

Radiology | October 17, 2023 | Volume: 309 | Issue: 1 | Pages: No page available

10.1148/radiol.230803 | PMID 37847140 Get It

Carbon Ion Radiotherapy: An Evidence-Based Review and Summary Recommendations of Clinical Outcomes for Skull-Base Chordomas and Chondrosarcomas
Holtzman, Adam L. , Seidensaal, Katharina , Iannalfi, Alberto , Kim, Kyung Hwan , Koto, Masashi , Yang, Wan-Chin, Shiau, Cheng-Ying, Mahajan, Anita , Peterson, Jennifer , Koffler, Daniel , Vallow, Laura A., Rutenberg, Michael S. , Ahmed, Safia K. , Peterson, Jennifer L., Koffler, Daniel M , Holtzman, Adam , Trifiletti, Daniel M. , Hoppe, Bradford S.

Cancers | October 17, 2023 | Volume: 15 | Issue: 20 | Pages: 5021

10.3390/cancers15205021 | PMID 37894388 Get It

Skull-base chordoma and chondrosarcoma are rare radioresistant tumors treated with surgical resection and/or radiotherapy. Because of the established dosimetric and biological benefits of heavy particle therapy, we performed a systematic and evidence-based review of the clinical outcomes of patients with skull-base chordoma and chondrosarcoma treated with carbon ion radiotherapy (CIRT). A literature review was performed using a MEDLINE search of all articles to date. We identified 227 studies as appropriate for review, and 24 were ultimately included. The published data illustrate that CIRT provides benchmark disease control outcomes for skull-base chordoma and chondrosarcoma, respectively, with acceptable toxicity. CIRT is an advanced treatment technique that may provide not only dosimetric benefits over conventional photon therapy but also biologic intensification to overcome mechanisms of radioresistance. Ongoing research is needed to define the magnitude of benefit, patient selection, and cost-effectiveness of CIRT compared to other forms of radiotherapy.
Extracellular Vesicles as Therapeutic and Diagnostic Tools for Chronic Liver Diseases
Leszczynska, Aleksandra , Sung, Hana, Povero, Davide , Eguchi, Akiko , Feldstein, Ariel E. , Stoess, Christian

Biomedicines | October 17, 2023 | Volume: 11 | Issue: 10 | Pages: 2808

10.3390/biomedicines11102808 | PMID 37893181 Get It

Chronic liver diseases can lead to fibrotic changes that may progress to the development of cirrhosis, which poses a significant risk for morbidity and increased mortality rates. Metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-associated liver disease (ALD), and viral hepatitis are prevalent liver diseases that may lead to cirrhosis. The advanced stages of cirrhosis can be further complicated by cancer development or end-stage liver disease and liver failure. Hence, early detection and diagnosis of liver fibrosis is crucial for preventing the progression to cirrhosis and improving patient outcomes. Traditionally, invasive liver biopsy has been considered the gold standard for diagnosing and staging liver fibrosis. In the last decade, research has focused on non-invasive methods, known as liquid biopsies, which involve the identification of disease-specific biomarkers in human fluids, such as blood. Among these alternative approaches, extracellular vesicles (EVs) have emerged as promising diagnostic and therapeutic tools for various diseases, including chronic liver diseases. EVs are released from stressed or damaged cells and can be isolated and quantified. Moreover, EVs facilitate cell-to-cell communication by transporting various cargo, and they have shown the potential to reduce the expression of profibrogenic markers, making them appealing tools for novel anti-fibrotic treatments. This review focuses on the impact of EVs in chronic liver diseases and exploring their potential applications in innovative therapeutic and diagnostic approaches.
Metabolic Remodeling during Early Cardiac Lineage Specification of Pluripotent Stem Cells
Bobori, Sunday Ndoma , Zhu, Yuxiang , Saarinen, Alicia M., Liuzzo, A, Saarinen, Alicia, Liuzzo, Alexis Josephine, Liuzzo, Alexis Josephine, Folmes, Clifford D.L.

Metabolites | October 17, 2023 | Volume: 13 | Issue: 10 | Pages: 1086

10.3390/metabo13101086 | PMID 37887411 Get It

Growing evidence indicates that metabolites and energy metabolism play an active rather than consequential role in regulating cellular fate. Cardiac development requires dramatic metabolic remodeling from relying primarily on glycolysis in pluripotent stem cells (PSCs) to oxidizing a wide array of energy substrates to match the high bioenergetic demands of continuous contraction in the developed heart. However, a detailed analysis of how remodeling of energy metabolism contributes to human cardiac development is lacking. Using dynamic multiple reaction monitoring metabolomics of central carbon metabolism, we evaluated temporal changes in energy metabolism during human PSC 3D cardiac lineage specification. Significant metabolic remodeling occurs during the complete differentiation, yet temporal analysis revealed that most changes occur during transitions from pluripotency to mesoderm (day 1) and mesoderm to early cardiac (day 5), with limited maturation of cardiac metabolism beyond day 5. Real-time metabolic analysis demonstrated that while hPSC cardiomyocytes (hPSC-CM) showed elevated rates of oxidative metabolism compared to PSCs, they still retained high glycolytic rates, confirming an immature metabolic phenotype. These observations support the opportunity to metabolically optimize the differentiation process to support lineage specification and maturation of hPSC-CMs.
I Fail; Therefore, I Can: Failure Mindset and Robotics Self-Efficacy in Early Adolescence
Ford, Calah J. , Mohr‐Schroeder, Margaret J. , Usher, Ellen L.

Education Sciences | October 17, 2023 | Volume: 13 | Issue: 10 | Pages: 1038

10.3390/educsci13101038 Get It

When students feel successful, they tend to be more confident in their capabilities (i.e., higher self-efficacy), which is associated with improved performance, engagement, and self-regulation. Yet, the way in which learners interpret their experiences is less well-understood. Learners’ views of failure (i.e., failure mindset) are potential lenses through which early adolescent learners perceive and interpret efficacy-relevant information. The relationship between failure mindset and self-efficacy may be particularly important to consider in STEM-related domains like robotics where failure is common. The purpose of this study was to investigate the relationship between young adolescents’ failure mindset and their robotics self-efficacy development. Using mixed methods, we considered how students’ reported failure mindset levels were related to what has made them more or less confident in robotics. We also considered the relationship between failure mindset and robotics self-efficacy. Overall, the findings suggest that early adolescent learners’ failure mindset is related to the efficacy-relevant information they pay attention to in robotics, and, in turn, is associated with their reported robotics self-efficacy. The details of these relationships varied between elementary and middle school students. As there is a social push to normalize failures in educational settings, findings from this study offer an important insight into how students may interpret those failures.
Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study
Nagaraj, Gayathri , Vinayak, Shaveta , Sun, Tianyi , Kuderer, Nicole M. , Bakouny, Ziad , Balmaceda, Nicole , Bilen, Mehmet Asım , Bindal, Poorva , Blau, Sibel , Bodin, Brianne E, Borno, Hala T. , Castellano, Cecilia A. , Choi, Horyun, Deeken, John F. , Desai, Aakash , Edwin, Natasha, Feldman, Lawrence , Flora, Daniel , Galsky, Matthew D. , Gonzalez, Cyndi J, Grivas, Petros , Gupta, Shilpa , Haynam, Marcy , Heilman, Hannah, Jani, Chinmay , Jhawar, Sachin R, Kaklamani, Virginia , Klein, Elizabeth J. , Koshkin, Vadim S. , Kulkarni, Amit , Kwon, Daniel H. , Lammers, Philip E. , Lathrop, Kate, Lewis, Mark A. , Li, Xuanyi , Lopes, Gilbert de Lima, Makower, Della , Mansoor, Abdul-Hai, Mashru, Sandeep H., McKay, Rana R. , Messing, Ian , Mico, Vasil, Nadkarni, Rajani, Namburi, Swathi, Nguyen, Ryan H, Nonato, Taylor K., O’Connor, Tracey L. , Park, Kyu, Patel, Jaymin , Patel, Kanishka G. , Peppercorn, Jeffrey , Polimera, Hyma , Puc, Matthew , Rao, Yuan James , Reid, Sonya , Riess, Jonathan W. , Rivera, Donna R. , Rose, Suzanne J. , Russ, Atlantis Dawn, Schapira, Lidia , Shah, Pankil , Shanahan, M Kelly, Smits, Melissa, Streckfuss, Mitrianna, Thompson, Michael A, Tolaney, Sara M. , Weissmann, Lisa B., Wilson, Grace, Wulff‐Burchfield, Elizabeth , French, Benjamin , Lustberg, Maryam B. , Accordino, Melissa , Sun, Tianyi , Hwang, Clara , Puc, Matthew M , Mishra, Sanjay , Accordino, Melissa K , Desai, Aakash P , Bakouny, Ziad , Bilen, Mehmet A , Lustberg, Maryam , Khaki, Ali Raza , Aboulafia, David M. , Acoba, Jared David , Awosika, Joy A. , Bao, Ting , Bashir, Babar , Berg, Stephanie , Friese, Christopher R. , Hershman, Dawn L. , Hwang, Clara , Jhawar, Sachin R, Joshi, Monika , Knox, Natalie, Labaki, Chris , Lyman, Gary H , Markham, Merry Jennifer , Nguyen, Ryan H, Panagiotou, Orestis A. , Razavi, Pedram , Robson, Mark E. , Shapiro, Lauren C. , Stover, Daniel G. , Tachiki, Lisa , Wotman, Michael T. , Mishra, Sanjay , Warner, Jeremy L. , Shah, Dimpy P.

eLife | October 17, 2023 | Volume: 12 | Issue: No issue available | Pages: No page available

10.7554/elife.82618 | PMID 37846664 Get It

Background: Limited information is available for patients with breast cancer (BC) and coronavirus disease 2019 (COVID-19), especially among underrepresented racial/ethnic populations. Methods: This is a COVID-19 and Cancer Consortium (CCC19) registry-based retrospective cohort study of females with active or history of BC and laboratory-confirmed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection diagnosed between March 2020 and June 2021 in the US. Primary outcome was COVID-19 severity measured on a five-level ordinal scale, including none of the following complications, hospitalization, intensive care unit admission, mechanical ventilation, and all-cause mortality. Multivariable ordinal logistic regression model identified characteristics associated with COVID-19 severity. Results: 1383 female patient records with BC and COVID-19 were included in the analysis, the median age was 61 years, and median follow-up was 90 days. Multivariable analysis revealed higher odds of COVID-19 severity for older age (aOR per decade, 1.48 [95% CI, 1.32–1.67]); Black patients (aOR 1.74; 95 CI 1.24–2.45), Asian Americans and Pacific Islander patients (aOR 3.40; 95 CI 1.70–6.79) and Other (aOR 2.97; 95 CI 1.71–5.17) racial/ethnic groups; worse ECOG performance status (ECOG PS ≥2: aOR, 7.78 [95% CI, 4.83–12.5]); pre-existing cardiovascular (aOR, 2.26 [95% CI, 1.63–3.15])/pulmonary comorbidities (aOR, 1.65 [95% CI, 1.20–2.29]); diabetes mellitus (aOR, 2.25 [95% CI, 1.66–3.04]); and active and progressing cancer (aOR, 12.5 [95% CI, 6.89–22.6]). Hispanic ethnicity, timing, and type of anti-cancer therapy modalities were not significantly associated with worse COVID-19 outcomes. The total all-cause mortality and hospitalization rate for the entire cohort was 9% and 37%, respectively however, it varied according to the BC disease status. Conclusions: Using one of the largest registries on cancer and COVID-19, we identified patient and BC-related factors associated with worse COVID-19 outcomes. After adjusting for baseline characteristics, underrepresented racial/ethnic patients experienced worse outcomes compared to non-Hispanic White patients. Funding: This study was partly supported by National Cancer Institute grant number P30 CA068485 to Tianyi Sun, Sanjay Mishra, Benjamin French, Jeremy L Warner; P30-CA046592 to Christopher R Friese; P30 CA023100 for Rana R McKay; P30-CA054174 for Pankil K Shah and Dimpy P Shah; KL2 TR002646 for Pankil Shah and the American Cancer Society and Hope Foundation for Cancer Research (MRSG-16-152-01-CCE) and P30-CA054174 for Dimpy P Shah. REDCap is developed and supported by Vanderbilt Institute for Clinical and Translational Research grant support (UL1 TR000445 from NCATS/NIH). The funding sources had no role in the writing of the manuscript or the decision to submit it for publication. Clinical trial number: CCC19 registry is registered on ClinicalTrials.gov, NCT04354701 .
Assessing mechanical function of peristalsis with functional lumen imaging probe panometry: Contraction power and displaced volume
Halder, Sourav , Pandolfino, John E. , Kahrilas, Peter J. , Koop, Andree , Schauer, Jacob M. , Araujo, Isis K. , Elisha, Guy , Kou, Wenjun , Patankar, Neelesh A. , Carlson, Dustin A.

Neurogastroenterology & Motility | October 17, 2023 | Volume: 35 | Issue: 12 | Pages: No page available

10.1111/nmo.14692 | PMID 37845833 Get It

AbstractBackground and AimsThe distal contractile integral (DCI) quantifies the contractile vigor of primary peristalsis on high‐resolution manometry (HRM), whereas no such metric exists for secondary peristalsis on functional lumen imaging probe (FLIP) panometry. This study aimed to evaluate novel FLIP metrics of contraction power and displaced volume in asymptomatic controls and a patient cohort.MethodsThirty‐five asymptomatic controls and adult patients (with normal esophagogastric junction outflow/opening and without spasm) who completed HRM and FLIP panometry were included. The patient group also completed timed barium esophagram (TBE). Contraction power (estimate of esophageal work over time) and displaced volume (estimate of contraction‐associated fluid flow) were computed from FLIP. HRM was analyzed per Chicago Classification v4.0.Key ResultsIn controls, median (5th–95th percentile) contraction power was 27 mW (10–44) and displaced volume was 43 mL (17–66). 95 patients were included: 72% with normal motility on HRM, 17% with ineffective esophageal motility (IEM), and 12% with absent contractility. Among patients, DCI was significantly correlated with both contraction power (rho = 0.499) and displaced volume (rho = 0.342); p values < 0.001. Both contraction power and displaced volume were greater in patients with normal motility versus IEM or absent contractility, complete versus incomplete bolus transit, and normal versus abnormal retention on TBE; p values < 0.02.ConclusionsFLIP panometry metrics of contraction power and displaced volume appeared to effectively quantify peristaltic vigor. These novel metrics may enhance evaluation of esophageal motility with FLIP panometry and provide a reliable surrogate to DCI on HRM.
Development of a model to identify patients who do not need oesophageal biopsies when eosinophilic oesophagitis is suspected
Kamboj, Amrit K. , Liu, Liang Yen , Tome, June , Snyder, Diana L. , Alexander, Jeffrey A. , Harmsen, William S. , Dellon, Evan S. , Katzka, David A. , Alexander, Jeffrey A , Katzka, D A , Tome, June , Cotton, Cary C. , Ravi, Karthik

Alimentary Pharmacology & Therapeutics | October 17, 2023 | Volume: 58 | Issue: 11-12 | Pages: 1143-1150

10.1111/apt.17772 | PMID 37845804 Get It

SummaryBackgroundPredictive models for eosinophilic oesophagitis (EoE) may not fully rule in the diagnosis.AimTo develop a reverse model that predicts against EoE to eliminate the need for oesophageal biopsies.MethodsIn this two‐centre study, a predictive model was developed (Mayo Clinic) and validated (University of North Carolina [UNC]). Cross‐sectional data from consecutive adult patients without prior EoE who underwent upper enoscopy with oesophageal biopsies were used. EoE cases had ≥15 eosinophils/high‐power field while controls had no eosinophils. Data were collected on patient clinical and endoscopic features. Multiple variable logistic regression was used to identify predictors of non‐EoE status while maintaining specificity ≥95%. A secondary model was developed to predict against the need for endoscopy in patients suspected of having EoE without alarm symptoms.ResultsThe Mayo and UNC cohorts consisted of 345 (EoE = 94, non‐EoE = 251) and 297 patients (EoE = 84, non‐EoE = 213), respectively. A primary model based on clinical and endoscopic features predicted against EoE with c‐statistic 0.92 (95% CI: 0.88–0.96), specificity 95%, and sensitivity 65%. This model was validated (UNC) with c‐statistic 0.87 (95% CI: 0.82–0.92). A simplified scoring system was created and a threshold of ≥12 points excluded EoE with 95% specificity and 50% sensitivity. A secondary model based on clinical characteristics alone predicted against EoE with c‐statistic 0.86 (95% CI: 0.82–0.90), specificity 95% and sensitivity 39% and validated (UNC) with c‐statistic 0.78 (95% CI: 0.71–0.85).ConclusionA simplified scoring system accurately identified a group of patients with a low likelihood of EoE where unnecessary oesophageal biopsies can be avoided, potentially resulting in resource and cost savings.
Clinical characteristics of infantile hemangiomas with aggressive, persistent, and destructive ulceration
Gautam, Ayushi , Frieden, Ilona J. , Shah, Sonal D. , Witman, Patricia M., Harfmann, Katya , Bradley, Flora , Blei, Francine , Pope, Elena , Alsumait, Anwar, Gupta, Deepti , Covelli, Isabela, Streicher, Jenna L., Cotton, Colleen , Tollefson, Megha M. , Nguyen, Henry, Hunt, Raegan , Buros, Amy, Fernandez Faith, Esteban , Gautam, Ayushi , Buros, Amy, Faith, Esteban Fernández

Pediatric Dermatology | October 17, 2023 | Volume: 40 | Issue: 6 | Pages: 996-1002

10.1111/pde.15444 | PMID 37845188 Get It

AbstractBackground/ObjectivesUlceration is a common complication of infantile hemangioma (IH). Severe, persistent ulceration occurs in a minority of patients. This study aims to characterize the clinical features of IH with aggressive ulceration (AU).MethodsMulticenter retrospective study of clinical features of IH with AU.ResultsThirty‐five patients with AU were identified and included in the study. The majority of AU occurred in segmental IH (23/35, 65%). Segmental IH with AU were large (≥10 cm2; 16/23, 69%, p < .001) with a thin (<3 mm) superficial component (16/23, 69%, p < .001). Localized IH with AU had a thick (>3 mm) superficial component (11/12, 92%, p < .001).All diaper area IH with AU (9/35) were segmental with thin superficial component (100%, p = .02). IH with AU in the head/neck (10/35) were more commonly localized (67%) and mixed (62.5%), while segmental, thick superficial morphology was more common on trunk (9/35) and upper extremities (7/35).ConclusionsIH resulting in AU differ in clinical features by anatomic site. Those in the diaper area are nearly always segmental with thin superficial component, whereas other sites tend to be localized, mixed, with thick superficial component. These distinct phenotypes may prove useful in the clinical setting for physicians to identify patterns of IH ulceration with increased risk of aggressive, persistent ulceration.
Digital Equity in Hematology-Oncology Fellowship Websites: Toward Standardization, Quality, and Transparency
Godby, Richard , Godby, Richard Curtis

JCO Oncology Practice | October 16, 2023 | Volume: 19 | Issue: 12 | Pages: 1093-1096

10.1200/op.23.00421 | PMID 37844266 Get It

Improving trainee program websites may help applicants and programs in the era of virtual interviews